Russia approves trial of AstraZeneca COVID-19 vaccine
(VOVWORLD) - Britain’s AstraZeneca (AZN.L) has received regulatory approval to conduct part of a Phase III trial of its potential COVID-19 vaccine in Russia, a filing in the Russian registry of clinical trials showed on Friday, according to Reuters.
 Made in Russia Covid-19 vaccine. Photo: Yonhap/VNA |
The trial of the AZD1222 vaccine will involve 150 participants and will be handled by four medical facilities in St. Petersburg and Moscow, the filing, dated Friday, showed.
Russia claimed that its state-run Gamaleya research institute has developed the first vaccine to fight COVID-19 nicknamed ‘Sputnik-V’, registered for circulation on August 11 after pre-clinical and clinical researchs. Russia said it may start to export the COVID-19 vaccines in spring of 2021 after ensuring domestic supplies.